Page last updated: 2024-08-21

1,2-naphthoquinone and Disease Models, Animal

1,2-naphthoquinone has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carroll, PJ; DuHadaway, JB; Jaller, D; Kumar, S; LaLonde, JM; Malachowski, WP; Metz, R; Muller, AJ; Prendergast, GC1
Kador, PF; Rodriguez, L; Sato, S; Simpson, JT; Sugiyama, K; Wang, TC1

Other Studies

2 other study(ies) available for 1,2-naphthoquinone and Disease Models, Animal

ArticleYear
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
    Journal of medicinal chemistry, 2008, Mar-27, Volume: 51, Issue:6

    Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Computer Simulation; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Knockout; Mice, Nude; Models, Molecular; Molecular Structure; Naphthoquinones; Pyrones; Stereoisomerism; Structure-Activity Relationship; Vitamin K 3

2008
Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone.
    Drug metabolism and disposition: the biological fate of chemicals, 1999, Volume: 27, Issue:1

    Topics: Aldehyde Reductase; Animals; Cataract; Cells, Cultured; Disease Models, Animal; Humans; Lens, Crystalline; Naphthols; Naphthoquinones; Oxidation-Reduction; Rats

1999